Lobbying

A.P. Goldshield's latest lobbying report covers Q1 2025, at under $5,000. Its first report covers Q4 2022; the issues it reports most are Health Issues and Chemicals/Chemical Industry.

A.P. Goldshield

Latest quarter
No record
Q3 2026 · 0 reports
Last 12 months
$0
Last 4 quarters
vs last quarter
No record
Q3 2026 against the quarter before
First report
Q4 2022
The first quarter a report named it

Lobbying by quarter

A.P. Goldshield lobbying by quarter
A.P. Goldshield lobbying by quarter
QuarterAmountReports
Q4 2022$10K1
Q1 2023$10K1
Q2 2023$10K1
Q3 2023$10K1
Q4 2023$10K1
Q1 2024$10K1
Q2 2024$10K1
Q3 2024$01
Q4 2024$01
Q1 2025$01
Q2 2025$00
Q3 2025$00
Q4 2025$00
Q1 2026$00
Q2 2026$00
Q3 2026$00

By issue

  • Health issues$38.3K · 7 reports
  • Chemicals$18.3K · 5 reports
  • Environment and Superfund$8,333 · 3 reports
  • Agriculture$5,000 · 2 reports
  • Immigration$0 · 1 reports

An issue's amount splits each report's amount equally over the issues the report lists.

Who was lobbied

  • Food & Drug Administration (FDA)6 reports
  • Commerce, Dept of (DOC)5 reports
  • Environmental Protection Agency (EPA)5 reports
  • HOUSE OF REPRESENTATIVES5 reports
  • SENATE4 reports
  • Health & Human Services, Dept of (HHS)2 reports
  • Agriculture, Dept of (USDA)1 reports
  • Centers For Disease Control & Prevention (CDC)1 reports
  • Smithsonian Institution1 reports

Firms it paid

Firm
Rem Strategies$70K10 quarters

Former officials lobbying for it

Former position
ROBERT E. MILLSlobbyist, President REM Strategies LLCQ2 2024

Lobbying reports

Filed by
25/04/17for Q1 2025Rem StrategiesUnder $5,000
25/01/20for Q4 2024Rem StrategiesUnder $5,000
24/10/21for Q3 2024Rem StrategiesUnder $5,000
24/07/16for Q2 2024Rem Strategies$10K
24/04/16for Q1 2024Rem Strategies$10K
24/01/18for Q4 2023Rem Strategies$10K
23/10/19for Q3 2023Rem Strategies$10K
23/07/19for Q2 2023Rem Strategies$10K
23/04/17for Q1 2023Rem Strategies$10K
23/01/19for Q4 2022Rem Strategies$10K